13D/13G Filings - DRIEHAUS CAPITAL MANAGEMENT INC

Real time Form 13D and 13G transaction reports:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
  • Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
Time period
Goto Prev, 0, 1, 2, Next
Reported
DateTime
Transaction
Date
Type Company
Symbol
Filed By
Symbol
Shares Owned
% Owned
Shares Vs. Prev Report View
2023-02-08
11:32 am
Purchase
2022-12-31 13G Crinetics Pharmaceuticals, Inc.
CRNX
DRIEHAUS CAPITAL MANAGEMENT INC 5,624,744
10.450%
831,106increase
(+17.34%)
Filing
History
2022-11-10
09:23 am
Sale
2022-10-31 13G DICE Therapeutics, Inc.
DICE
DRIEHAUS CAPITAL MANAGEMENT INC 1,915,496
4.020%
-231,146decrease
(-10.77%)
Filing
History
2022-10-13
1:29 pm
Sale
2022-10-04 13G Calidi Biotherapeutics, Inc.
CLDI
DRIEHAUS CAPITAL MANAGEMENT INC 20,000
4.840%
-80,000decrease
(-80.00%)
Filing
History
2022-10-11
08:55 am
Sale
2022-09-30 13G Calidi Biotherapeutics, Inc.
CLDI
DRIEHAUS CAPITAL MANAGEMENT INC 100,000
24.220%
-50,000decrease
(-33.33%)
Filing
History
2022-07-11
10:28 am
Sale
2022-06-08 13G Elevation Oncology, Inc.
ELEV
DRIEHAUS CAPITAL MANAGEMENT INC 1,044,244
4.490%
-458,524decrease
(-30.51%)
Filing
History
2022-06-15
11:28 am
Purchase
2021-11-30 13G The Real Good Food Company, Inc.
RGF
DRIEHAUS CAPITAL MANAGEMENT INC 66,405
12.920%
66,405increase
(New Position)
Filing
History
2022-06-13
1:50 pm
Purchase
2021-12-31 13G MELI Kaszek Pioneer Corp
MEKA
DRIEHAUS CAPITAL MANAGEMENT INC 1,957,541
6.590%
1,957,541increase
(New Position)
Filing
History
2022-06-10
09:02 am
Sale
2022-05-31 13G Elevation Oncology, Inc.
ELEV
DRIEHAUS CAPITAL MANAGEMENT INC 1,502,768
6.460%
-479,695decrease
(-24.20%)
Filing
History
2022-04-08
09:47 am
Sale
2022-03-31 13G ChannelAdvisor Corporation
ECOM
DRIEHAUS CAPITAL MANAGEMENT INC 1,421,532
4.670%
-674,297decrease
(-32.17%)
Filing
History
2022-02-14
09:42 am
Sale
2021-12-31 13G Cytokinetics, Incorporated
CYTK
DRIEHAUS CAPITAL MANAGEMENT INC 2,327,112
2.770%
-712,144decrease
(-23.43%)
Filing
History
2022-02-14
09:28 am
Purchase
2021-12-31 13G Calidi Biotherapeutics, Inc.
CLDI
DRIEHAUS CAPITAL MANAGEMENT INC 150,000
5.220%
150,000increase
(New Position)
Filing
History
2022-02-14
09:24 am
Purchase
2021-12-31 13G DICE Therapeutics, Inc.
DICE
DRIEHAUS CAPITAL MANAGEMENT INC 2,146,642
5.610%
2,146,642increase
(New Position)
Filing
History
2022-02-14
09:19 am
Purchase
2021-12-31 13G Elevation Oncology, Inc.
ELEV
DRIEHAUS CAPITAL MANAGEMENT INC 1,982,463
8.540%
1,982,463increase
(New Position)
Filing
History
2022-02-14
09:14 am
Purchase
2021-12-31 13G Xenon Pharmaceuticals Inc.
XENE
DRIEHAUS CAPITAL MANAGEMENT INC 3,123,229
6.050%
3,123,229increase
(New Position)
Filing
History
2022-01-10
11:09 am
Purchase
2021-12-31 13G Crinetics Pharmaceuticals, Inc.
CRNX
DRIEHAUS CAPITAL MANAGEMENT INC 4,793,638
10.090%
4,793,638increase
(New Position)
Filing
History
2021-10-04
10:03 am
Purchase
2021-09-14 13G RumbleON, Inc.
RMBL
DRIEHAUS CAPITAL MANAGEMENT INC 346,146
2.300%
83,976increase
(+32.03%)
Filing
History
2021-08-23
4:55 pm
Sale
2021-08-16 13G ESSA Pharma Inc.
EPIX
DRIEHAUS CAPITAL MANAGEMENT INC 0
0.000%
-1,048,524decrease
(Position Closed)
Filing
History
2021-05-10
09:44 am
Purchase
2021-04-09 13G RumbleON, Inc.
RMBL
DRIEHAUS CAPITAL MANAGEMENT INC 262,170
11.430%
262,170increase
(New Position)
Filing
History
2021-02-16
09:42 am
Unchanged
2020-12-31 13G ESSA Pharma Inc.
EPIX
DRIEHAUS CAPITAL MANAGEMENT INC 1,048,524
5.030%
0
(Unchanged)
Filing
History
2021-02-16
09:40 am
Unchanged
2020-12-31 13G ChannelAdvisor Corporation
ECOM
DRIEHAUS CAPITAL MANAGEMENT INC 2,095,829
7.230%
0
(Unchanged)
Filing
History
Goto Prev, 0, 1, 2, Next